Special circumstances regarding expanded access at Stanford In most circumstances, medical research using investigational drugs, biologics and devices

First Page		Document Content
Date: 2016-04-12 01:21:50 Health Medical research Clinical pharmacology Pharmaceutical industry Food and Drug Administration Design of experiments Clinical research Expanded access Clinical trial Institutional review board Treatment IND Investigational device exemption		Special circumstances regarding expanded access at Stanford In most circumstances, medical research using investigational drugs, biologics and devices Add to Reading List Source URL: humansubjects.stanford.edu Download Document from Source Website File Size: 327,79 KB Share Document on Facebook

	The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis DocID: 1vrwY - View Document
	Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather DocID: 1vpIt - View Document
	Clinical Research Registration at Public Registry DocID: 1vnxr - View Document
	Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im DocID: 1vi9N - View Document
	Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location DocID: 1vglz - View Document